Recombinant antibodies: Engineering and production in yeast and bacterial hosts

Biotechnology Journal

Volumn 6, Issue 1, 2011, Pages 16-27

  Jeong, Ki Jun ^a   Jang, Seung Hoon ^a   Velmurugan, Natarajan ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Antibody; Fc engineering; Glycosylation; Production; Synthetic library

Indexed keywords

ANTIBODY ENGINEERING; CELLULAR ENGINEERING; CELLULAR NETWORK; FC ENGINEERING; HIGH-THROUGHPUT SCREENING; HUMAN DISEASE; INFECTIOUS DISEASE; NEW TECHNOLOGIES; RECENT PROGRESS; RECOMBINANT ANTIBODY; SYNTHETIC LIBRARY; SYSTEMS BIOLOGY; THERAPEUTIC AGENTS;

BACTERIOLOGY; CELLULAR NEURAL NETWORKS; ENGINEERING; ESTERIFICATION; GLYCOSYLATION; YEAST;

ANTIBODIES;

FC RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT ANTIBODY;

ANTIBODY ENGINEERING; ANTIBODY PRODUCTION; BACTERIUM; BINDING AFFINITY; DRUG MANUFACTURE; DRUG RECEPTOR BINDING; ESCHERICHIA COLI; GLYCOSYLATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; YEAST;

BACTERIA; IMMUNOGLOBULIN FC FRAGMENTS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; YEASTS;

BACTERIA (MICROORGANISMS);

EID: 78651301416     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201000381     Document Type: Review

References (67)

1. Li, J., Zhu, Z., Research and development of next generation of antibody-based therapeutics. Acta Pharmacol. Sin. 2010, 31, 1198-1207.
2. Lobo, E. D., Hansen, R. J., Balthasar, J. P., Antibody pharmacokinetics and pharmacodynamics. J. Pharm. Sci. 2004, 93, 2645-2668.
3. Idusogie, E. E., Presta, L. G., Gazzano-Santoro, H., Totpal, K. et al., Mapping of the C1q binding site on Rituxan, a chimeric antibody with a human IgG1 Fc. J. Immunol. 2000, 164, 4178-4184.
4. Shields, R. L., Namenuk, A. K., Hong, K., Meng, Y. G. et al., High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR. J. Biol. Chem. 2001, 276, 6591-6604.
5. Stavenhagen, J. B., Gorlatov, S., Tuaillon, N., Rankin, C. T. et al., Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcγ receptors. Cancer Res. 2007, 67, 8882-8890.
6. Vaccaro, C., Zhou, J., Ober, R. J., Ward, E. S., Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat. Biotechnol. 2005, 23, 1283-1288.
7. Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y. et al., Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity. J. Biol. Chem. 2002, 277, 26733-26740.
8. Liu, X. Y., Pop, L. M., Vitetta, E. S., Engineering therapeutic monoclonal antibodies. Immunol. Rev. 2008, 222, 9-27.
9. Petkova, S. B., Akilesh, S., Sproule, T. J., Christianson, G. J. et al., Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int. Immunol. 2006, 18, 1759-1769.
10. Vaccaro, C., Zhou, J., Ober, R. J., Ward, E. S., Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat. Biotechnol. 2005, 23, 1283-1288.
11. Igawa, T., Tsunoda, H., Tachibana, T., Maeda, A. et al., Reduced elimination of IgG antibodies by engineering the variable region. Protein Eng. Des. Sel. 2010, 23, 385-392.
12. Zalevsky, J., Chamberlain, A. K., Horton, H. M., Karki, S. et al., Enhanced antibody half-life improves in vivo activity. Nat. Biotechnol. 2010, 28, 157-159.
13. Wozniak-Knopp, G., Bartl, S., Bauer, A., Mostageer, M. et al., Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties. Protein Eng. Des. Sel. 2010, 23, 289-297.
14. Li, H., Sethuraman, N., Stadheim, T. A., Zha, D. et al., Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat. Biotechnol. 2006, 24, 210-215.
15. Kowarik, M., Young, N. M., Numao, S., Schulz, B. L. et al., Definition of the bacterial N-glycosylation site consensus sequence. EMBO J. 2006, 25, 1957-1966.
16. Skretas, G., Carroll, S., DeFrees, S., Schwartz, M. et al., Expression of active human sialyltransferase ST6GalNAcI in Escherichia coli. Microb. Cell Fact. 2009, 8, 50.
17. Schwarz, F., Huang, W., Li, C., Schulz, B. L. et al., A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation. Nat. Chem. Biol. 2010, 6, 264-266.
18. Sazinsky, S. L., Ott, R. G., Silver, N. W., Tidor, B. et al., Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors. Proc. Natl. Acad. Sci. USA 2008, 105, 20167-20172.
19. Jung, S. T., Reddy, S. T., Kang, T. H., Borrok, M. J. et al., Aglycosylated IgG variants expressed in bacteria that selectively bind FcγRI potentiate tumor cell killing by monocyte-dendritic cells. Proc. Natl. Acad. Sci. USA 2010, 107, 604-609.
20. Jung, S. T., Kang, T. H., Georgiou, G., Efficient expression and purification of human aglycosylated Fcgamma receptors in Escherichia coli. Biotechnol. Bioeng. 2010, 107, 21-30.
21. Rodrigues, M. E., Costa, A. R., Henriques, M., Azeredo, J. et al., Technological progresses in monoclonal antibody production systems. Biotechnol. Prog. 2010, 26, 332-351.
22. Wurm, F. M., Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 2004, 22, 1393-1398.
23. Farid, S. S., Process economics of industrial monoclonal antibody manufacture. J. Chromatogr. 2007, 848, 8-18.
24. Gasser, B., Maurer, M., Gach, J., Kunert, R. et al., Engineering of Pichia pastoris for improved production of antibody fragments. Biotechnol. Bioeng. 2006, 94, 353-361.
25. Gasser, B., Mattanovich, D., Antibody production with yeasts and filamentous fungi: On the road to large scale? Biotechnol. Lett. 2007, 29, 201-212.
26. Rakestraw, J. A., Sazinsky, S. L., Piatesi, A., Antipov, E. et al., Directed evolution of a secretory leader for the improved expression of heterologous proteins and full-length antibodies in Saccharomyces cerevisiae. Biotechnol. Bioeng. 2009, 103, 1192-1201.
27. Damasceno, L., Anderson, K., Ritter, G., Cregg, J. et al., Cooverexpression of chaperones for enhanced secretion of a single-chain antibody fragment in Pichia pastoris. Appl. Microbiol. Biotechnol. 2007, 74, 381-389.
28. Borth, N., Mattanovich, D., Kunert, R., Katinger, H., Effect of increased expression of protein disulfide isomerase and heavy chain binding protein on antibody secretion in a recombinant CHO cell line. Biotechnol. Prog. 2005, 21, 106-111.
29. Valkonen, M., Penttila, M., Saloheimo, M., Effects of inactivation and constitutive expression of the unfolded-protein response pathway on protein production in the yeast Saccharomyces cerevisiae. Appl. Environ. Microbiol. 2003, 69, 2065-2072.
30. Dragosits, M., Stadlmann, J., Graf, A., Gasser, B. et al., The response to unfolded protein is involved in osmotolerance of Pichia pastoris. BMC Genome. 2010, 11, 207.
31. Potgieter, T. I., Cukan, M., Drummond, J. E., Houston-Cummings, N. R. et al., Production of monoclonal antibodies by glycoengineered Pichia pastoris. J. Biotechnol. 2009, 139, 318-325.
32. Potgieter, T. I., Kersey, S. D., Mallem, M. R., Nylen, A. C. et al., Antibody expression kinetics in glycoengineered Pichia pastoris. Biotechnol. Bioeng. 2010, 106, 918-927.
33. Xia, X. X., Qian, Z. G., Ki, C. S., Park, Y. H. et al., Native-sized recombinant spider silk protein produced in metabolically engineered Escherichia coli results in a strong fiber. Proc. Natl. Acad. Sci. USA 2010, 107, 14059-14063.
34. Hayhurst, A., Happe, S., Mabry, R., Koch, Z. et al., Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis. J. Immunol. Methods 2003, 276, 185-196.
35. Bothmann, H., Pluckthun, A., The periplasmic Escherichia coli peptidylprolyl cis, trans-isomerase FkpA. I. Increased functional expression of antibody fragments with and without cis-prolines. J. Biol. Chem. 2000, 275, 17100-17105.
36. Ying, B. W., Taguchi, H., Ueda, H., Ueda, T., Chaperone-assisted folding of a single-chain antibody in a reconstituted translation system. Biochem. Biophys. Res. Commun. 2004, 320, 1359-1364.
37. Sonoda, H., Kumada, Y., Katsuda, T., Yamaji, H., Functional expression of single-chain Fv antibody in the cytoplasm of Escherichia coli by thioredoxin fusion and co-expression of molecular chaperones. Protein Expr. Purif. 2010, 70, 248-253.
38. Zheng, L., Baumann, U., Reymond, J.-L., Production of a functional catalytic antibody ScFv-NusA fusion protein in bacterial cytoplasm. J. Biochem. 2003, 133, 577-581.
39. Chen, C., Snedecor, B., Nishihara, J. C., Joly, J. C. et al., High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain. Biotechnol. Bioeng. 2004, 85, 463-474.
40. Ribnicky, B., Van Blarcom, T., Georgiou, G., A scFv antibody mutant isolated in a genetic screen for improved export via the twin arginine transporter pathway exhibits faster folding. J. Mol. Biol. 2007, 369, 631-639.
41. Jeong, K. J., Seo, M. J., Iverson, B. L., Georgiou, G., APEx 2-hybrid, a quantitative protein-protein interaction assay for antibody discovery and engineering. Proc. Natl. Acad. Sci. USA 2007, 104, 8247-8252.
42. Horn, U., Strittmatter, W., Krebber, A., Knüpfer, U. et al., High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions. Appl. Microbiol. Biotechnol. 1996, 46, 524-532.
43. Carter, P., Kelley, R. F., Rodrigues, M. L., Snedecor, B. et al., High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Nat. Biotechnol. 1992, 10, 163-167.
44. Simmons, L. C., Reilly, D., Klimowski, L., Shantha Raju, T. et al., Expression of full-length immunoglobulins in Escherichia coli: Rapid and efficient production of aglycosylated antibodies. J. Immunol. Methods 2002, 263, 133-147.
45. Steiner, D., Forrer, P., Stumpp, M. T., Pluckthun, A., Signal sequences directing cotranslational translocation expand the range of proteins amenable to phage display. Nat. Biotechnol. 2006, 24, 823-831.
46. Puertas, J. M., Nannenga, B. L., Dornfeld, K. T., Betton, J. M., Enhancing the secretory yields of leech carboxypeptidase inhibitor in Escherichia coli: Influence of trigger factor and signal recognition particle. Protein Expr. Purif. 2010, 74, 122-128.
47. Aldor, I. S., Krawitz, D. C., Forrest, W., Chen, C. et al., Proteomic profiling of recombinant Escherichia coli in high-cell-density fermentations for improved production of an antibody fragment biopharmaceutical. Appl. Environ. Microbiol. 2005, 71, 1717-1728.
48. Levy, R., Weiss, R., Chen, G., Iverson, B. L. et al., Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones. Protein Expr. Purif. 2001, 23, 338-347.
49. Seo, M. J., Jeong, K. J., Leysath, C. E., Ellington, A. D. et al., Engineering antibody fragments to fold in the absence of disulfide bonds. Protein Sci. 2009, 18, 259-267.
50. Fernandez, L. A., Enjuanes, L., de Lorenzo, V., Specific secretion of active single-chain Fv antibodies into the supernatants of Escherichia coli cultures by use of the hemolysin system. Appl. Environ. Microbiol. 2000, 66, 5024-5029.
51. Chan, C. E. Z., Lim, A. P. C., Chan, A. H. Y., MacAry, P. A. et al., Optimized expression of full-length IgG1 antibody in a common E. coli strain. PLoS ONE. 2010, 5, e10261.
52. Simmons, L. C., Klimowski, L., Reilly, D., Yansura, D. G., Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes. US patent 697955. 2005.
53. Reilly, D., Yansura, D., Methods and compositions for increasing antibody production. US Patent 7608429. 2009.
54. Mazor, Y., Van Blarcom, T., Mabry, R., Iverson, B. L. et al., Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. Nat. Biotechnol. 2007, 25, 563-565.
55. Shiroza, T., Shinozaki-Kuwahara, N., Hayakawa, M., Shibata, Y. et al., Production of a single-chain variable fraction capable of inhibiting the Streptococcus mutans glucosyltransferase in Bacillus brevis: Construction of a chimeric shuttle plasmid secreting its gene product. Biochim Biophys Acta 2003, 1626, 57-64.
56. Wu, S. C., Yeung, J. C., Duan, Y., Ye, R. et al., Functional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: Effects of molecular chaperones and a wall-bound protease on antibody fragment production. Appl. Environ. Microbiol. 2002, 68, 3261-3269.
57. Jordan, E., Hust, M., Roth, A., Biedendieck, R. et al., Production of recombinant antibody fragments in Bacillus megaterium. Microb. Cell Fact. 2007, 6, 2.
58. Goerke, A. R., Swartz, J. R., Development of cell-free protein synthesis platforms for disulfide bonded proteins. Biotechnol. Bioeng. 2008, 99, 351-367.
59. Ali, M., Suzuki, H., Fukuba, T., Jiang, X. et al., Improvements in the cell-free production of functional antibodies using cell extract from protease-deficient Escherichia coli mutant. J. Biosci. Bioeng. 2005, 99, 181-186.
60. Damasceno, L. M., Pla, I., Chang, H. J., Cohen, L. et al., An optimized fermentation process for high-level production of a single-chain Fv antibody fragment in Pichia pastoris. Protein Expr. Purif. 2004, 37, 18-26.
61. Khatri, N., Hoffmann, F., Oxygen-limited control of methanol uptake for improved production of a single-chain antibody fragment with recombinant Pichia pastoris. Appl. Microbiol. Biotechnol. 2006, 72, 492-498.
62. Yamawaki, S., Matsumoto, T., Ohnishi, Y., Kumada, Y. et al., Production of single-chain variable fragment antibody (scFv) in fed-batch and continuous culture of Pichia pastoris by two different methanol feeding methods. J. Biosci. Bioeng. 2007, 104, 403-407.
63. Ning, D., Junjian, X., Qing, Z., Sheng, X. et al., Production of recombinant humanized anti-HBsAg Fab fragment from Pichia pastoris by fermentation. BMB Rep. 2005, 38, 294-299.
64. Sotiriadis, A., Keshavarz, T., Keshavarz-Moore, E., Factors affecting the production of a single-chain antibody fragment by Aspergillus awamori in a stirred tank reactor. Biotechnol. Prog. 2001, 17, 618-623.
65. Forsberg, G., Forsgren, M., Jaki, M., Norin, M. et al., Identification of framework residues in a secreted recombinant antibody fragment that control production level and localization in Escherichia coli. J. Biol. Chem. 1997, 272, 12430-12436.
66. Sletta, H., Nedal, A., Aune, T. E. V., Hellebust, H. et al., Broad-host-range plasmid pJB658 can be used for industrial-level production of a secreted host-toxic single-chain antibody fragment in Escherichia coli. Appl. Environ. Microbiol. 2004, 70, 7033-7039.
67. Kumada, Y., Sakan, Y., Kajihara, H., Kihara, M. et al., Efficient production of single-chain Fv antibody possessing rare codon linkers in fed-batch fermentation. J. Biosci. Bioeng. 2009, 107, 73-77.